Cottu P, Coudert B, Perol D, Doly A, et al. Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2-targeted treatments: Results from the french personalized reimbursement model database (2011-2018) Eur J Cancer 2020;141:209-217.
PMID: 33176232